Girao Tiago has filed 5 insider transactions across 1 company since May 2025.
Most recent transaction: a sale of 25760 shares of Immunovant, Inc. ($IMVT) on April 23, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 23, 2026 | Immunovant, Inc. | $IMVT | Girao Tiago | Chief Financial Officer | S | Common Stock | 25760 | $29.62 | 247,596.0000 | 203,532,180 | 9.42% | 0.01% |
| April 7, 2026 | Immunovant, Inc. | $IMVT | Girao Tiago | Chief Financial Officer | A | Common Stock | 64968 | $0.00 | 273,356.0000 | 203,532,180 | 31.18% | 0.03% |
| April 7, 2026 | Immunovant, Inc. | $IMVT | Girao Tiago | Chief Financial Officer | A | Stock Option (right to buy) | 94002 | $0.00 | 94,002.0000 | 203,532,180 | 9999.99% | 0.05% |
| May 1, 2025 | Immunovant, Inc. | $IMVT | Girao Tiago | Chief Financial Officer | A | Common Stock | 208388 | $0.00 | 208,388.0000 | 0 | 9999.99% | 0.00% |
| May 1, 2025 | Immunovant, Inc. | $IMVT | Girao Tiago | Chief Financial Officer | A | Stock Option (Right to Buy) | 293505 | $0.00 | 293,505.0000 | 0 | 9999.99% | 0.00% |